Fiche publication


Date publication

janvier 2008

Journal

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Auteurs

Membres identifiés du Cancéropôle Est :
Pr MASCAUX Céline


Tous les auteurs :
Berghmans T, Dusart M, Paesmans M, Hossein-Foucher C, Buvat I, Castaigne C, Scherpereel A, Mascaux C, Moreau M, Roelandts M, Alard S, Meert AP, Patz EF, Lafitte JJ, Sculier JP,

Résumé

The 2-[18F]-fluoro-2-deoxy-d-glucose positron emission tomography is an imaging tool for assessing clinical tumor, node, metastasis in non-small cell lung cancer (NSCLC). Primary tumor standardized uptake value (SUV) has been studied as a potential prognostic factor for survival. However, the sample sizes are limited leading to conduct a meta-analysis to improve the precision in estimating its effect.

Mots clés

Carcinoma, Non-Small-Cell Lung, diagnosis, Female, Fluorodeoxyglucose F18, pharmacokinetics, Humans, Lung Neoplasms, diagnosis, Neoplasm Staging, Positron-Emission Tomography, methods, Prognosis, Survival Analysis

Référence

J Thorac Oncol. 2008 Jan;3(1):6-12